Why the EU should support the standardization of health outcomes measurements

18 October 2018
efpia-big-3

When the European Commission published its report on the State of Health in the European Union last year, it recognized five ongoing trends in health system reform: shifting to prevention, stronger primary care, integration of care, supporting a resilient health workforce and developing better patient-centered data.

All these developments are important to make European healthcare systems more sustainable despite mounting pressure from an ageing population and multi-morbidities. The fifth trend however, which is also the most aspirational one, is the key to making European healthcare systems truly patient-centered and outcomes-based, comments Thomas Allvin, executive director, strategy and healthcare systems at trade group the European Federation of Pharmaceutical Industries and Associations (EFPIA) in a blog posting.

What do we mean by outcomes-based?

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical